The new portable monitor enables accurate and real-time combined CH4, H2 and O2 monitoring allowing health professionals to accurately detect a range of gastrointestinal disorders and is the latest addition to the Bedfont Gastrolyzer® family.
Using the GastroCH4ECK™ offers clinicians access to online breath sampling for instant results to assist diagnosis with problems such as carbohydrate malabsorption, lactose intolerance, bacterial overgrowth, and determination of time passage through gut.
Jason Smith, Sales & Marketing Manager for Bedfont said “we are pleased to have finalised registration in Italy, this now means we are able to offer this innovative monitor to italian healthcare professionals to enable fast and accurate test results ensuring their patients receive an optimum level of gastrointestinal care”
